[go: up one dir, main page]

GR3034096T3 - A method for treatment of patients with chronic liver disease. - Google Patents

A method for treatment of patients with chronic liver disease.

Info

Publication number
GR3034096T3
GR3034096T3 GR20000401793T GR20000401793T GR3034096T3 GR 3034096 T3 GR3034096 T3 GR 3034096T3 GR 20000401793 T GR20000401793 T GR 20000401793T GR 20000401793 T GR20000401793 T GR 20000401793T GR 3034096 T3 GR3034096 T3 GR 3034096T3
Authority
GR
Greece
Prior art keywords
patients
pct
liver disease
chronic liver
treatment
Prior art date
Application number
GR20000401793T
Other languages
English (en)
Inventor
Niels Erik Skakkebaek
Soeren Moeller
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of GR3034096T3 publication Critical patent/GR3034096T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
GR20000401793T 1991-09-05 2000-08-02 A method for treatment of patients with chronic liver disease. GR3034096T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK911554A DK155491D0 (da) 1991-09-05 1991-09-05 Behandling af patienter med kronisk leversygdom
PCT/DK1992/000245 WO1993004694A1 (en) 1991-09-05 1992-08-18 A method for treatment of patients with chronic liver disease

Publications (1)

Publication Number Publication Date
GR3034096T3 true GR3034096T3 (en) 2000-11-30

Family

ID=8106016

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401793T GR3034096T3 (en) 1991-09-05 2000-08-02 A method for treatment of patients with chronic liver disease.

Country Status (11)

Country Link
US (1) US5492891A (el)
EP (1) EP0602172B1 (el)
JP (1) JP3105541B2 (el)
AT (1) ATE192656T1 (el)
AU (1) AU664201B2 (el)
CA (1) CA2116535C (el)
DE (1) DE69231036T2 (el)
DK (2) DK155491D0 (el)
ES (1) ES2148180T3 (el)
GR (1) GR3034096T3 (el)
WO (1) WO1993004694A1 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401045A (nl) * 1994-03-15 1995-10-02 Leuven K U Res & Dev Nieuw gebruik van groeihormoon.
AU1942995A (en) * 1994-03-15 1995-10-03 K.U. Leuven Research & Development New use of growth hormone
US5705482A (en) * 1995-01-13 1998-01-06 Novo Nordisk A/S Pharmaceutical formulation
JP3869874B2 (ja) * 1995-11-15 2007-01-17 大日本住友製薬株式会社 急性肝不全治療剤
ES2146530B1 (es) * 1997-12-26 2001-04-16 Consejo Superior Investigacion Utilizacion del factor de crecimiento igf-i en la fabricacion de composiciones utiles en el tratamiento de la ataxia cerebelar.
RU2204399C1 (ru) * 2001-12-29 2003-05-20 Челябинский государственный институт лазерной хирургии Способ патогенетического лечения хронических заболеваний печени в эксперименте
RU2203675C1 (ru) * 2001-12-29 2003-05-10 Челябинский государственный институт лазерной хирургии Способ патогенетической терапии хронических заболеваний печени
CA2495395C (en) * 2002-06-20 2013-01-08 Bionethos Holding Gmbh Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
MXPA05004384A (es) 2002-10-23 2005-10-18 Johnson & Johnson Piperacinil y diacepanil benzamidas y benztioamidas.
BRPI0409877A (pt) * 2003-04-30 2006-05-16 Kanga Kenji Wa agentes preventivos ou remédios para doenças hepáticas
EP1574211A1 (en) 2004-03-09 2005-09-14 Inserm Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
RU2333020C1 (ru) * 2007-04-05 2008-09-10 Государственное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей Федерального агентства по здравоохранению и социальному развитию" Способ реабилитации больных с постхолецистэктомическим синдромом

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898857A (en) * 1984-10-29 1990-02-06 Chaovanee Aroonsakul Treating control nervous system diseases
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
WO1991011195A1 (en) * 1990-02-02 1991-08-08 Novo Nordisk A/S A method of treating a mammal with a biologically active compound

Also Published As

Publication number Publication date
US5492891A (en) 1996-02-20
EP0602172B1 (en) 2000-05-10
DK0602172T3 (da) 2000-10-02
JP3105541B2 (ja) 2000-11-06
AU2579892A (en) 1993-04-05
JPH06510292A (ja) 1994-11-17
DE69231036D1 (de) 2000-06-15
ATE192656T1 (de) 2000-05-15
CA2116535C (en) 2000-10-31
DK155491D0 (da) 1991-09-05
ES2148180T3 (es) 2000-10-16
EP0602172A1 (en) 1994-06-22
DE69231036T2 (de) 2000-11-02
WO1993004694A1 (en) 1993-03-18
CA2116535A1 (en) 1993-03-18
AU664201B2 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
ZA923980B (en) Hepatocyte Growth stimulation
GR3034096T3 (en) A method for treatment of patients with chronic liver disease.
BG104141A (bg) Лечебни и хранителни състави, съдържащи незаменими мастни киселини и биоактивни дисулфиди
ES2043890T3 (es) Nuevo uso medico.
MX9604635A (es) Tratamiento del sindrome de insensibilidad parcial a la hormona del crecimiento.
EP1201241B8 (en) Compositions containing capsaicin or capsaicin analogues and an anesthetic
GR3023874T3 (en) Igf-1 to improve the neural condition.
ATE185268T1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
MY109862A (en) A short infusion methods for administration of paclitaxel
GEP20002146B (en) Therapeutic Peptide Derivatives
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
AU7473096A (en) Continuous low-dose cytokine infusion therapy
DE69533868D1 (de) Glucagon-ähnliche insulinotrope Peptid-Analoge, Zusammensetzungen und Verwendungsverfahren
ZA89813B (en) Method for treating renal diseases
AU3402295A (en) Methods and means for drug administration
SE9201573D0 (sv) Use of igf-1
IL161889A0 (en) Method for treating diseases with omega interferon
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
SE9300105D0 (sv) Stable protein solution
EP0515434A4 (en) Method for treating intestinal diseases
CA2252560A1 (en) Treatment of partial growth hormone insensitivity syndrome
SE9002731D0 (sv) Product comprising growth factor
NO960866D0 (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler
James Successful treatment of" buffalo hump" with growth hormone
MX9708628A (es) TRATAMIENTO DE LA DIABETES DE TIPO II CON ALTAS DOSIS DE PICOLINATO CRaMICO.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees